RSS

Medicines and Healthcare products Regulatory Agency (MHRA)

The MHRA has reiterated guidance that it has previously given regarding the regulations of medicines if the UK leaves the European Union without a deal. Read more

News

Patients taking medicines for Parkinson’s, epilepsy and blood clots are being warned to check if their prescriptions are part of certain batches of recalled medicines. Read more

News

Heather Oebel, NPI enterprise solutions manager at Winshuttle examines the changing drug landscape and why pharmaceutical companies need to go digital with their data. Read more

Opinion

EPM editor Reece Armstrong examines the impact a no-deal Brexit would place on medicines supply in the UK. Read more

Opinion

With the end result of Brexit fast approaching, labelling supplier Kallik looks at the implications Brexit could place on labelling and compliance in the pharmaceutical sector. Read more

Opinion

The Medicines and Healthcare products Regulatory Agency (MRHA) has announced a pharmacy level recall of a blood pressure drug made by Mylan and Teva. Read more

News

Five non-critical highly potent products supplied by contract development and manufacturing organisation (CDMO) Recipharm have had their manufacturing licence restricted. Read more

News

A haul of fake medicines worth over £2 million was seized by the Medicines and Healthcare products Regulatory Agency (MHRA) in a crackdown on counterfeit and unlicensed drugs. Read more

News

In preparations for Brexit, the EMA has redistributed the UK’s product portfolio to other EU members and is not allocating any centralised marketing authorisation applications to the MHRA. We take a closer look… Read more

Opinion

The Association of the British Pharmaceutical Industry (ABPI) has responded to the recent publication of the Medicines and Healthcare products Regulatory Agency (MHRA) technical guidance on what the Brexit implementation means for life sciences. Read more

News

Some medicines containing valsartan used for the treatment of high blood pressure and heart conditions are being recalled across Europe to be reviewed by the European Medicines Agency (EMA) to determine the extent of ingredient impurity. Read more

News

Specialty pharmaceutical company, Alliance Pharma, has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has approved the UK marketing authorisation application for Diclectin. Read more

News

‘Doing nothing is not an option’ is the overriding message from pharmaceutical experts who attended the recent Pharmaceutical Industry Network Group (PING) seminar, held in conjunction with Ethical Medicines Industry Group (EMIG). Read more

News

Specialty pharmaceutical company, Alliance Pharma, has revealed that following discussions with the MHRA and the CHM, the marketing authorisation application for Diclectin is now considered approvable. Read more

News

Virgin Atlantic Cargo has been granted a wholesale distribution authorisation (WDA) for its global headquarters operations and its new Pharma Zone at Heathrow Airport, which confirms the airline’s compliance with good distribution practice (GDP) Read more

News

The Medicines and Healthcare products Regulatory Agency (MHRA) has implemented changes to the licence for valproate medicines — Epilim, Depakote and generics used to treat epilepsy and bipolar disorder — in the interest of public safety. Read more

News

Recent analysis from the Medicines and Healthcare products Regulatory Agency (MHRA) has revealed that black market trading in top strength Diazepam (10 mg) has dropped by more than 60% Read more

News

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a positive opinion to Akcea Therapeutics’ volanesorsen for the treatment of familial chylomicronaemia syndrome (FCS) under the Early Access to Medicines Scheme (EAMS). Read more

News

A patient and a pharmacy level drug alert recall has been issued by the Medicines and Healthcare products Regulatory Agency (MHRA) for three specific lots of asthma inhalers as they may not deliver the full number doses Read more

News

The Association of the British Pharmaceutical Industry (ABPI) has issued its reaction to the publication of the Medicines and Healthcare products Regulatory Agency’s (MHRA) update to pharma companies on preparing for Brexit. Read more

News